Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells. | Redox Biol | 2024 | 38184997 | PubTator, text mining | PubMed |
| Mesenchymal-epithelial transition and AXL inhibitor TP-0903 sensitise triple-negative breast cancer cells to the antimalarial compound, artesunate. | Sci Rep | 2024 | 38172210 | PubTator, text mining | PubMed |
| Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma. | Theranostics | 2024 | 38169544 | PubTator, text mining | PubMed |
| N-acetyltransferase 10 regulates alphavirus replication via N4-acetylcytidine (ac4C) modification of the lymphocyte antigen six family member E (LY6E) mRNA. | J Virol | 2024 | 38169284 | PubTator, text mining | PubMed |
| Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept. | J Exp Clin Cancer Res | 2024 | 38167055 | PubTator, text mining | PubMed |
| Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches. | Theranostics | 2024 | 38164138 | PubTator, text mining | PubMed |
| Particulate matter composition drives differential molecular and morphological responses in lung epithelial cells. | PNAS Nexus | 2024 | 38156290 | PubTator, text mining | PubMed |
| HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS. | Neurol Neuroimmunol Neuroinflamm | 2024 | 38150649 | PubTator, text mining | PubMed |
Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation. | J Enzyme Inhib Med Chem | 2024 | 38134358 | PubTator, text mining | PubMed |
| First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof-of-concept study. | Cancer Med | 2024 | 38132919 | PubTator, text mining | PubMed |
| Research progress of extracellular vesicles in the treatment of ovarian diseases (Review). | Exp Ther Med | 2024 | 38125352 | PubTator, text mining | PubMed |
| Roles of vitamin K‑dependent protein in biomineralization (Review). | Int J Mol Med | 2024 | 37997858 | PubTator, text mining | PubMed |
| Identifying the Interaction Between Tuberculosis and SARS-CoV-2 Infections via Bioinformatics Analysis and Machine Learning. | Biochem Genet | 2024 | 37991568 | PubTator, text mining | PubMed |
| GAS6 attenuates sepsis-induced cardiac dysfunction through NLRP3 inflammasome-dependent mechanism. | Free Radic Biol Med | 2024 | 37979891 | PubTator, text mining | PubMed |
| Engineering Heterogeneous Tumor Models for Biomedical Applications. | Adv Sci (Weinh) | 2024 | 37946674 | PubTator, text mining | PubMed |
| Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD-L1 in Cancer Therapy. | Adv Sci (Weinh) | 2024 | 37934012 | PubTator, text mining | PubMed |
| Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells. | Mol Cancer Ther | 2024 | 37802502 | PubTator, text mining | PubMed |
| Influence of serum Gas6 levels on prognosis in patients with hepatocellular carcinoma. | Jpn J Clin Oncol | 2024 | 37801445 | PubTator, text mining | PubMed |
| Exploring the Therapeutic Potential of Fe3O4@Glu-Oleuropein Nanoparticles in Targeting KRAS Pathway-Regulating lncRNAs in Colorectal Cancer Cells. | Biol Trace Elem Res | 2024 | 37792268 | PubTator, text mining | PubMed |
| Signaling pathways governing the behaviors of leukemia stem cells. | Genes Dis | 2024 | 37692500 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=14